ESHRE/LinkedIn
Sep 10, 2026, 16:18
New Human Reproduction Press Release on Paracetamol Use During Pregnancy – ESHRE
European Society of Human Reproduction and Embryology (ESHRE) shared on LinkedIn:
”New Human Reproduction Press Release.
Researchers in Denmark have found that girls whose mothers took paracetamol during pregnancy had smaller ovaries, fewer ovarian follicles (the structures that contain immature eggs), smaller uteruses and lower levels of reproductive hormones at three months old, according to a study published in Human Reproduction Open, one of the world’s leading reproductive medicine journals.
Read the entire press release here.”
Other articles featuring ESHRE on Fertility News.
-
Nov 14, 2026, 11:15Karthik Raj: Caesarean Scar Defect and Secondary Infertility
-
Nov 14, 2026, 11:06Mervat Alkarkatli: The IVF Laboratory Clock
-
Nov 14, 2026, 10:59Esther Eleboh: Improving Fertility and Preconception Health – Actionable Steps
-
Nov 14, 2026, 08:46Clare Mansfield: A Thoughtful Gift for a New Chapter in a Family’s Life
-
Nov 14, 2026, 08:31Supreet Kumar Has Been Appointed Laboratory Director at Heartland Fertility in Winnipeg
-
Nov 13, 2026, 17:25From Contraception to Fertility Treatment, Reproductive Health Care Is a Human Right – ASRM
-
Nov 13, 2026, 17:15Discussing Planned Committee Projects and Much More with the ESGO Council
-
Nov 13, 2026, 17:08Don’t Forget the Male: An Interview with Francesco Lotti – ESHRE
-
Nov 13, 2026, 16:57Amos Grünebaum: 8 Tools, 1 Pregnancy, All Free
